China Manufacturers >> Hefei Amedcare Import and Export Trade Co., Ltd. >>

Company Profile

Company Profile

Business Type: Manufacturer,Trading Company
Main Products:

Chinese Medicine

Number of Employees: 4~10
Annual Turnover: Above US$100 Million

Hefei Amedcare Import & Export Trade Co., Ltd. is a foreign trade department of Anhui Topsun Pharmaceutical Co. Ltd.
We are committed to the production, research and development of drugs and sales. Our production has passed through GMP quality system certification, and strictly in accordance with the GMP standard production and inspection. Our factory is 18000 squre meters, 3 buliding workshops, 2building warehouse and 1 laboratory. And now, we have 210 emplyees, among which 67 are professional technicians. And our sales have passed the GSP certification, which has 2000 square meters GSP cool storehouse.
At present, we can produce and sell dosage forms: Pure herbal medicine concentrated pills, pure herbal medicine concentrated tablets, pure herbal capsules, syrup oral liquid, all kinds of herbal tea, slimming tea, etc. We can also provide OEM and ODM services.
We have strict quality assurance and after-sales service. If the products have quality problems within the validity period, we will actively deal with them to ensure customer satisfaction.
Looking forward to cooperating with you!
Business Type: Manufacturer/Factory,Trading Company
Plant Area: 101~500 Square Meters
International Commercial Terms: FOB, CFR, CIF, DDP, Others
Terms of Payment: LC, T/T, D/P, PayPal, Western Union, Small-amount payment, Money Gram
Average Lead Time: Peak season lead time: 1-3 monthsOff season lead time: one month
Number of Foreign Trading Staff: 4~10 People
Export Year: 2005-10-08
Export Percentage: 21%~30%
Main Markets: North America, Southeast Asia, Africa, Mid East
Export Mode: Have Own Export License
Factory Address: Guoqing Road 26#,Huainan City ,Anhui Province
R&D Capacity: OEM, ODM, Own Brand()
No. of R&D Staff: 11-20 People
No. of Production Lines: 5
Annual Output Value: Above US$100 Million